D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALEX
1751
DELISTED
Alexander & Baldwin
ALEX
| $4.62M | 0.01% |
+220,412
| New | +$4.99M |
|
1752
iShares Biotechnology ETF
IBB
$9.52B
| $4.61M | 0.01% |
+38,250
| New | +$4.27M |
|
1753
Ventas
VTR
$44.7B
| $4.61M | 0.01% |
79,841
+61,617
| +338% | +$3.87M |
|
|
TBRG
1754
DELISTED
TruBridge
TBRG
| $4.61M | 0.01% |
174,497
+24,859
| +17% | +$620K |
|
1755
PUT
The Greenbrier Companies
GBX
$1.52B
| $4.6M | 0.01% |
141,800
-39,200
| -22% | -$1.17M |
|
1756
Allegiant Air
ALGT
$2.66B
| $4.6M | 0.01% |
26,414
+13,399
| +103% | +$2.22M |
|
1757
CALL
WEC Energy
WEC
$35.8B
| $4.58M | 0.01% |
49,700
+23,500
| +90% | +$2.14M |
|
1758
PUT
Phillips 66
PSX
$84.4B
| $4.56M | 0.01% |
40,900
-57,400
| -58% | -$6.45M |
|
|
APLS
1759
DELISTED
Apellis Pharmaceuticals
APLS
| $4.54M | 0.01% |
148,407
+137,342
| +1,241% | +$3.8M |
|
1760
CALL
Huntington Ingalls Industries
HII
$12.6B
| $4.54M | 0.01% |
+18,100
| New | +$4.29M |
|
|
DPLO
1761
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $4.54M | 0.01% |
1,134,345
-29,662
| -3% | -$139K |
|
1762
AZZ Inc
AZZ
$4.36B
| $4.53M | 0.01% |
98,674
+24,941
| +34% | +$1.02M |
|
1763
Arvinas
ARVN
$536M
| $4.52M | 0.01% |
+109,937
| New | +$3.22M |
|
1764
Banner Corp
BANR
$2.37B
| $4.52M | 0.01% |
79,812
+5,020
| +7% | +$278K |
|
|
GWB
1765
DELISTED
Great Western Bancorp, Inc.
GWB
| $4.51M | 0.01% |
129,935
+24,564
| +23% | +$849K |
|
1766
PTC
PTC
$15.7B
| $4.51M | 0.01% |
60,228
+55,022
| +1,057% | +$3.91M |
|
1767
CALL
PVH
PVH
$4.01B
| $4.49M | 0.01% |
42,700
-3,400
| -7% | -$324K |
|
1768
Regal Rexnord
RRX
$13.5B
| $4.48M | 0.01% |
52,336
+25,872
| +98% | +$2.05M |
|
|
ZUO
1769
DELISTED
Zuora, Inc.
ZUO
| $4.48M | 0.01% |
312,627
+102,209
| +49% | +$1.5M |
|
1770
CALL
Raymond James Financial
RJF
$33.6B
| $4.47M | 0.01% |
75,000
| – | – |
|
1771
Pebblebrook Hotel Trust
PEB
$2.12B
| $4.46M | 0.01% |
166,276
+91,837
| +123% | +$2.42M |
|
|
MIC
1772
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $4.46M | 0.01% |
104,036
-61,147
| -37% | -$2.52M |
|
|
WBK
1773
DELISTED
Westpac Banking Corporation
WBK
| $4.45M | 0.01% |
262,007
+241,713
| +1,191% | +$4.37M |
|
1774
CALL
Sysco
SYY
$40.6B
| $4.45M | 0.01% |
+52,000
| New | +$4.21M |
|
|
CLVS
1775
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.45M | 0.01% |
426,531
-1,335,983
| -76% | -$9.71M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.